GSK - GlaxoSmithKline plc (GSK) Management Presents at 42nd Annual Cowen Health Care Conference (Transcript)

GlaxoSmithKline plc (GSK) 42nd Annual Cowen Health Care Conference Call March 7, 2022 11:10 ET Company Participants Hal Barron - Chief Scientific Officer and President, Research and Development Conference Call Participants Stephen Scala - Cowen & Company Presentation Stephen Scala Good morning and welcome once again. We are here with the top management of GlaxoSmithKline at Cowen’s 42nd Annual Healthcare Conference. We are very, very pleased to have with us, Dr. Hal Barron who is Chief Scientific Officer and President of Research and Development. Dr. Barron has shown over the last 30 or so years that he is clearly one of the industry’s most prolific drug development experts. So, it’s always great to have conversations with him. Question-and-Answer Session Q - Stephen Scala So, Hal thanks again for your time this morning. I’d like to start out and ask, What do you believe have been your greatest accomplishments in RD

For further details see:

GlaxoSmithKline plc (GSK) Management Presents at 42nd Annual Cowen Health Care Conference (Transcript)